Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRevolution Medicines, Inc. Warrant Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | -$0.94 | $0 | |||
| 08/07/2024 | Q2 2024 | -$0.81 | $0 | |||
| 05/08/2024 | Q1 2024 | -$0.70 | $0 | |||
| 02/26/2024 | Q4 2023 | -$1.14 | $742,000 | |||
| 11/06/2023 | Q3 2023 | -$0.99 | $0 | |||
| 08/08/2023 | Q2 2023 | -$0.92 | $3.82 M | |||
| 05/08/2023 | Q1 2023 | -$0.62 | $7.01 M | |||
| 02/27/2023 | Q4 2022 | -$0.63 | $15.33 M | |||
| 11/07/2022 | Q3 2022 | -$0.87 | $3.36 M | |||
| 08/09/2022 | Q2 2022 | -$0.81 | $9.12 M | |||
| 05/09/2022 | Q1 2022 | -$0.77 | $7.58 M | |||
| 02/28/2022 | Q4 2021 | -$0.71 | $9.46 M | |||
| 11/10/2021 | Q3 2021 | -$0.72 | $1.10 M | |||
| 08/11/2021 | Q2 2021 | -$0.60 | $8.70 M | |||
| 05/10/2021 | Q1 2021 | -$0.53 | $10.13 M | |||
| 03/02/2021 | Q4 2020 | -$0.52 | $8.75 M | |||
| 11/12/2020 | Q3 2020 | -$0.42 | $12.66 M | |||
| 08/10/2020 | Q2 2020 | -$0.46 | $10.03 M | |||
| 05/14/2020 | Q1 2020 | -$0.67 | $11.55 M | |||
| 03/30/2020 | Q4 2019 | -$0.40 | $12.09 M |
Revolution Medicines, Inc. Warrant Earnings: FAQ's
How can I listen to Revolution Medicines, Inc. Warrant's earnings conference
call?
The conference call for Revolution Medicines, Inc. Warrant's latest earnings report can be listened to online.
How can I read Revolution Medicines, Inc. Warrant's conference call transcript?
The conference call transcript for Revolution Medicines, Inc. Warrant's latest earnings report can be read online.
How much revenue does Revolution Medicines, Inc. Warrant generate each year?
Revolution Medicines, Inc. Warrant (:RVMDW) has a recorded annual revenue of $11.58 M.
How much profit does Revolution Medicines, Inc. Warrant generate each year?
Revolution Medicines, Inc. Warrant (:RVMDW) has a recorded net income of $11.58 M. Revolution Medicines, Inc. Warrant has generated $-3.86 earnings per share over the last four quarters.
What is Revolution Medicines, Inc. Warrant's price-to-earnings ratio?
Revolution Medicines, Inc. Warrant (:RVMDW) has a price-to-earnings ratio of -13.13 and price/earnings-to-growth ratio is -9.56.